What is Sanofi Consumer Healthcare India Days Payable?
Sanofi Consumer Healthcare IndiaNSE:SANOFICONR +1.34%32 Days Payable is 129.24 as of Mar. 2026, which is 24% above its 10-year median of 103.93. GuruFocus rates NSE:SANOFICONR with a GF Score™ of 32/100. The stock has 2 warning signs investors should review. Among 927 Drug Manufacturers companies, Sanofi Consumer Healthcare India ranks better than 65.48% on this metric.
The historical rank and industry rank for Sanofi Consumer Healthcare India's Days Payable or its related term are showing as below:
NSE:SANOFICONR'
s Days Payable Range Over the Past 10 Years
Min: 97.77 Med: 103.93 Max: 119.45
Current: 119.45
During the past 3 years, Sanofi Consumer Healthcare India's highest Days Payable was 119.45. The lowest was 97.77. And the median was 103.93.
NSE:SANOFICONR's Days Payable is ranked better than 65.48% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs NSE:SANOFICONR: 119.45
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanofi Consumer Healthcare India Days Payable Chart
NSE:SANOFICONR vs LLY, JNJ, ABBV: Days Payable Comparison
For the Drug Manufacturers - General subindustry, Sanofi Consumer Healthcare India's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sanofi Consumer Healthcare India Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sanofi Consumer Healthcare India's Days Payable distribution charts can be found below:
* The bar in red indicates where Sanofi Consumer Healthcare India's Days Payable falls into.
Sanofi Consumer Healthcare India Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a Days Payable of 129.24 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sanofi Consumer Healthcare India and its competitors. This is 24% above median its historical median of 103.93. Over the past decade, Sanofi Consumer Healthcare India's Days Payable has ranged from 97.77 to 119.45. According to the industry distribution chart, Sanofi Consumer Healthcare India ranks #320 out of 927 companies in the Drug Manufacturers industry, placing it in the top 34.5%.
Is Sanofi Consumer Healthcare India's Days Payable too high?
Sanofi Consumer Healthcare India's current Days Payable of 129.24 is 24% above median its 10-year median of 103.93. Over the past 10 years, this metric has ranged from a low of 97.77 to a high of 119.45. The Drug Manufacturers industry median Days Payable is 90.38. Sanofi Consumer Healthcare India's value of 129.24 is 43% above this industry median. Based on the distribution chart, Sanofi Consumer Healthcare India ranks #320 out of 927 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Sanofi Consumer Healthcare India has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Sanofi Consumer Healthcare India's Days Payable compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Sanofi Consumer Healthcare India ranks #320 out of 927 companies for Days Payable. This puts Sanofi Consumer Healthcare India in the upper half of its industry. The industry median Days Payable is 90.38. Sanofi Consumer Healthcare India's value of 129.24 is 43% above this benchmark. Historically, Sanofi Consumer Healthcare India's own Days Payable has ranged from 97.77 to 119.45 over the past decade. While the company's 10-year median is 103.93 vs. the industry median of 90.38, Sanofi Consumer Healthcare India has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sanofi Consumer Healthcare India's current Days Payable of 129.24 is 43% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sanofi Consumer Healthcare India and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sanofi Consumer Healthcare India's current Days Payable is 129.24, which is 24% above median its own 10-year median of 103.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanofi Consumer Healthcare India stock overvalued right now?
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a current Days Payable of 129.24. The current Days Payable is 129.24, which is 24% above median its 10-year median of 103.93 and 43% above the Drug Manufacturers industry median of 90.38. Sanofi Consumer Healthcare India's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Sanofi Consumer Healthcare India (NSE:SANOFICONR), the current Days Payable is 129.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sanofi Consumer Healthcare India Business Description
Sanofi Consumer Healthcare India Ltd is mainly engaged in the business of manufacturing and trading of drugs and pharmaceutical products. The Company also has various independent contract/third-party manufacturers based across the country and provides business support services to its group entity in India. Its products include Allergy Relief (Allegra), Pain Care (Combiflam), and Physical Wellness (DePURA). The Company sells its products in India through independent distributors and outside India. Its operations are limited to one segment, namely Pharmaceutical Business. The Company operates in India, which generates the maximum revenue, and Outside India.
32GF Score
Get the complete analysis for NSE:SANOFICONR
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SANOFICONR has been successfully added to your 
